168 related articles for article (PubMed ID: 17652997)
1. [The histamine H3 receptor: a new target for the treatment of arousal and cognitive disorders].
Arrang JM
Ann Pharm Fr; 2007 Jul; 65(4):275-84. PubMed ID: 17652997
[TBL] [Abstract][Full Text] [Related]
2. [The histamine H(3) receptor: a target for new drugs].
Arrang JM
Ann Pharm Fr; 2003 May; 61(3):173-84. PubMed ID: 12714930
[TBL] [Abstract][Full Text] [Related]
3. Histamine H3-receptor inverse agonists as novel antipsychotics.
Ito C
Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):132-6. PubMed ID: 20021346
[TBL] [Abstract][Full Text] [Related]
4. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
[TBL] [Abstract][Full Text] [Related]
5. Histamine-selective H3 receptor ligands and cognitive functions: an overview.
Vohora D
IDrugs; 2004 Jul; 7(7):667-73. PubMed ID: 15243869
[TBL] [Abstract][Full Text] [Related]
6. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders.
Esbenshade TA; Browman KE; Bitner RS; Strakhova M; Cowart MD; Brioni JD
Br J Pharmacol; 2008 Jul; 154(6):1166-81. PubMed ID: 18469850
[TBL] [Abstract][Full Text] [Related]
7. The histamine H3 receptor as a therapeutic drug target for CNS disorders.
Gemkow MJ; Davenport AJ; Harich S; Ellenbroek BA; Cesura A; Hallett D
Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of histamine H3 receptor agonists and antagonists.
Leurs R; Blandina P; Tedford C; Timmerman H
Trends Pharmacol Sci; 1998 May; 19(5):177-83. PubMed ID: 9652190
[TBL] [Abstract][Full Text] [Related]
9. [Possible roles of brain histamine H3 receptors and the pharmacology of its ligands].
Onodera K; Watanabe T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):87-102. PubMed ID: 7796325
[TBL] [Abstract][Full Text] [Related]
10. The histamine H3 receptor: from gene cloning to H3 receptor drugs.
Leurs R; Bakker RA; Timmerman H; de Esch IJ
Nat Rev Drug Discov; 2005 Feb; 4(2):107-20. PubMed ID: 15665857
[TBL] [Abstract][Full Text] [Related]
11. Overview: H3 histamine receptor isoforms: new therapeutic targets in the CNS?
Chazot PL; Hann V
Curr Opin Investig Drugs; 2001 Oct; 2(10):1428-31. PubMed ID: 11890359
[No Abstract] [Full Text] [Related]
12. [The histaminergic system: a target for innovative treatments of cognitive deficits].
Motawaj M; Burban A; Davenas E; Gbahou F; Faucard R; Morisset S; Arrang JM
Therapie; 2010; 65(5):415-22. PubMed ID: 21144476
[TBL] [Abstract][Full Text] [Related]
13. H3 receptor antagonists/inverse agonists as anti-obesity agents.
Hancock AA
Curr Opin Investig Drugs; 2003 Oct; 4(10):1190-7. PubMed ID: 14649210
[TBL] [Abstract][Full Text] [Related]
14. Role of the Histamine H
Schlicker E; Kathmann M
Handb Exp Pharmacol; 2017; 241():277-299. PubMed ID: 27787717
[TBL] [Abstract][Full Text] [Related]
15. Histamine H3 receptor as a drug discovery target.
Berlin M; Boyce CW; Ruiz Mde L
J Med Chem; 2011 Jan; 54(1):26-53. PubMed ID: 21062081
[No Abstract] [Full Text] [Related]
16. Effects of histamine H3 receptor ligands in experimental models of anxiety and depression.
Pérez-García C; Morales L; Cano MV; Sancho I; Alguacil LF
Psychopharmacology (Berl); 1999 Feb; 142(2):215-20. PubMed ID: 10102775
[TBL] [Abstract][Full Text] [Related]
17. Some observations on airborne particles in blow-fill-seal filling rooms.
Sundström S; Ljungqvist B; Reinmüller B
PDA J Pharm Sci Technol; 2007; 61(3):147-53. PubMed ID: 17722481
[TBL] [Abstract][Full Text] [Related]
18. Modulation of neurotransmitter release via histamine H3 heteroreceptors.
Schlicker E; Malinowska B; Kathmann M; Göthert M
Fundam Clin Pharmacol; 1994; 8(2):128-37. PubMed ID: 8020871
[TBL] [Abstract][Full Text] [Related]
19. Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system.
Witkin JM; Nelson DL
Pharmacol Ther; 2004 Jul; 103(1):1-20. PubMed ID: 15251226
[TBL] [Abstract][Full Text] [Related]
20. The histamine H3 receptor: from discovery to clinical trials with pitolisant.
Schwartz JC
Br J Pharmacol; 2011 Jun; 163(4):713-21. PubMed ID: 21615387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
